(NASDAQ: PRCT) Procept Biorobotics's forecast annual revenue growth rate of 27.51% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.15%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.33%.
Procept Biorobotics's revenue in 2025 is $249,121,000.On average, 5 Wall Street analysts forecast PRCT's revenue for 2025 to be $17,878,795,120, with the lowest PRCT revenue forecast at $17,850,134,870, and the highest PRCT revenue forecast at $17,899,930,671. On average, 5 Wall Street analysts forecast PRCT's revenue for 2026 to be $23,313,951,492, with the lowest PRCT revenue forecast at $22,955,864,353, and the highest PRCT revenue forecast at $23,939,054,784.
In 2027, PRCT is forecast to generate $28,532,440,801 in revenue, with the lowest revenue forecast at $27,503,880,863 and the highest revenue forecast at $29,716,474,296.